🇺🇸 FDA
Patent

US 6602715

13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

expired A61KA61K51/1206

Quick answer

US patent 6602715 (13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control) held by Isotechnika, Inc. expires Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Isotechnika, Inc.
Grant date
Tue Aug 05 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K51/1206